Screener
| Segment | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 |
|---|---|---|---|---|---|---|---|---|
| Livmarli | $59.13M | $64.09M | $73.22M | $88.16M | $92.24M | $106.39M | $113.8M | $128.72M |
| Bile Acid Medicines | $31.18M | $35.34M | $38.36M | $39.63M | $40.78M | $42.55M | $46.08M | $47.52M |
| Total | $90.38M | $99.41M | $111.59M | $127.79M | $133.01M | $148.93M | $159.88M | $176.24M |